Milestone

2008

  • Planning to start a Pharmaceutical Unit.

 

2009

  • February- Formation Of Partnership Organization
  • March- 1st Product Submission In TRINIDAD
  • October- ISO 9001: 2008 Certified

2010

  • June - 1st Product Registration in JAMAICA
  • June- MOH supply to TNT
  • October- Start up of Domestic Operation

2011

  • February - MOH supply to JAMAICA
  • April- MOH supply to CUBA
  • May- MOH supply to EL SALVADOR
  • October- Subsidiary Office in US
  • August – Formation Of Private Organization

2012

  • March - MOH supply to PANAMA
  • April -1st Product Registration in PANAMA
  • November- 1st Product Registration in TNT
  • Development of New Product – Hydralazine Hydrochloride Injection USP
  • Development of New Product – Capecitabine Tablets USP
  • Development of New Product –Bleomycin Injection USP
  • Development of New Product –Doxorubicin Hydrochloride Injection USP

2013

  • Jan- 1st Product Registration in HONDURAS
  • July- MOH supply to JORDAN
  • September-1st Product Registration in DR
  • October- 1st Product Registration in EL SALVADOR
  • December- 1st Product Registration in CUBA
  • Development of New Product –Teicoplanin Injection
  • Development of New Product –Tigecycline Injection
  • Development of New Product –Premetrexed Injection

2014

  • Development of New Product – Alprostadil Injection USP
  • Development of New Product – Labetalol Hydrochloride Injection USP
  • Development of New Product – Milrinone Lactate Injection
  • Development of New Product – Caffeine Citrate Injection

2015

  • Tech Transfer-Loratadine Oral solution USP 5mg/5ml
  • 3 products submitted in specialty injectable and oncology segment

2016

  • Tech Transfer –Bisoprolol Tablet in all strength
  • Won tender for Antipsychotic range in Srilanka
  • Received 9 registration in Srilanka
  • 1st Product Registered in Cambodia
  • Received 1St Registration in Namibia
  • Introduced 30 plus New Formulation (products) for various markets across the Globe
  • Room temperature Stable Leucovorin Injection Introduced in Papua New Guinea Market
  • Purchase our own Manufacturing Plant which are specialized in Niche Liquid Injectable, Ophthalmic Range, and Derma Range.
  • Registration of high end oncology products
  • Initiated with private market in Jamaica & Dominican Republic
  • CE Marked products supplied in Regulated market
  • Supplied Biotechnology products in regulated market like Germany
  • 2 products registered in large volume Parental segment IV fluid in Antibiotic and Antifungal Therapy for Turkmenistan

2017

  • 1st Product registration in Botswana
  • 1st Product registration in Mongolia
  • 1st Product registration in Myanmar
  • Enter in Bosnia (EU) Market
  • Successfully Entered into Peru Market
  • Won Tender in Burundi, Guyana, Libya & Iraq Market

2018

  • Plant  ISO  10002:2014 certified
  • 1st registration received in Ecuador
  • 1st oncology product registered in Nigeria
  • 1st  antipsychotic product registered in Cuba
  • Received 44 registrations in Honduras & 12 registrations in Myanmar
  • Received overall 105 product registrations & 76 product submissions in various countries

 

2019

  • Received 1st approval of one Novel product from CDSCO, India
  • 1st registration received  in Uzbekistan, Laos, Georgia, Curacao
  • Enter in Madagascar Market-1st product submitted
  • Received 24 registrations in Honduras , 11  registrations in Myanmar, 5 oncology products in Nigeria
  • Received overall 80 product registrations  & 59 product submissions in various countries
  • 1st Technology transfer -Algeria
  • New product developed:
  • Latanoprost eye drops
  • Latanoprost + Timolol eye drops
  • Ciprofloxacin +Dexamethasone Eye drops
  • Ivermectin Cream & Lotion
  • Hydroquinone cream 4%w/w
  • Octreotide Acetate Injection 0.1mg & 0.05mg
  • Trypan blue 0.06% ophthalmic solution
  • Dexamethasone phosphate and neomycin eye/ear drops
  • Carbomer eye gel 0.2%
  • Naphazolin +Zinc sulphate  eye drops (100 mcg +0.2 mg)
  • Levocarnitin injection 200mg/ml
  • Glycopyrolate Injection 0.2 mg/ml
  • Glycopyrolate  + Neostigmine Injection
  • Dexpanthenol 5% ointment
  • Naphazoline 0.025 % w/w+ Phenylephrine HCl 0.25% w/v Nasal drops 
  • HPMC eye gel 0.3%
  • Tranexamic acid injection
  • Nepafenac eye suspension

2020

  • Company approval received from Bahamas
  • Plant Inspection by Yemen Ministry
  • 1st registration received from DR Congo, Ghana FDA, Bhutan, Peru
  • Received overall 45 product registrations & 66 product submissions  in various countries
  • Set up of new FND  facility
  • New product developed:
  • Citicoline injection
  • Nalbuphine injection
  • Travoprost Eye drop
  • Travoprost + timolol eye drops
  • Phenytoin injection
  • Ergocalciferol injection
  • Neomycin+ Polymyxin + Bacitacin ointment
  • Dimethicon lotion 4%
  • Granisetron Hydrochloride Injection
  • Bupivacaine and Adrenaline (Epinephrine) Injection
  • Metamizole 100mg/ml injection
  • Pancuronium bromide injection 2mg/ml
  • Flumazenil injection 0.5mg/ml
  • Cisatracurium Injection 2mg/ml
  • Buprenorphin injection 0.3%
  • Enoxaparin injection 100mg/ml, 3ml
  • Naphazolin nasal drops 0.5%
  • Acyclovir injection 25mg/ml
  • Zinc gluconate injection1mg/ml

2021

  • Crossed INR 1 BN
  • 1st Overseas Acquisition
  • Entry In API Business Market
  • High Quality PFS Inline Facility Available
  • Received approval of Methylene Blue Injection 0.1% w/v (Blue Beam) from CDSCO, India.
  • Plant renewed by NMRA (Sri Lanka)
  • Plant equipped with new PFS facility
  • 1st Narcotic analgesic product (Fentanyl injection) registered in Peru & Bolivia
  • 1st registration of Veterinary product  in Azerbaijan
  • Enter in Kenya market: received 2 products registration
  • 1st approval of Nutraceuticals in Myanmar (5 products)
  • Submission of Biological products in Latam
  • Site registration submitted for Philippines & Nepal
  • Enter in new markets like Brazil, Niger, Cameroon, Ivory coast, Chad, Gabon, Benin, Mali, Senegal, Burkina Faso, Gambia, Saudi Arabia, Venezuela, Armenia, Aruba, etc
  • New product developed:
  • Trace elements injection USP
  • Aminocaproic acid injection
  • Ivermectin +Closantel injection
  • Bepotastine eye drops 1.5%w/v
  • Levobunolol eye drops BP 0.5%
  • Desmopressin injection 4mcg
  • KY Jelly
  • Lignocaine Jelly
  • Palonosetron Injection
  • Zinc stearate ointment
  • Azithromycin eye drops
  • Vitamin AD3E & B-complex Injection